Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy
- 1 June 1990
- journal article
- Published by Elsevier BV in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 188 (6), 335-347
- https://doi.org/10.1016/0922-4106(90)90194-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Amphetamine discrimination: effects of dopamine receptor agonistsEuropean Journal of Pharmacology, 1989
- The D-1 dopamine receptor partial agonist, CY 208–243, exhibits antiparkinsonian activity in the MPTP-treated marmosetEuropean Journal of Pharmacology, 1988
- Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brainEuropean Journal of Pharmacology, 1988
- Specific binding of 3H-SCH 23390 to dopamine D1 receptorsLife Sciences, 1986
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Binding of [3H]SCH23390 in Rat Brain: Regional Distribution and Effects of Assay Conditions and GTP Suggest Interactions at a D1-Like Dopamine ReceptorJournal of Neurochemistry, 1985
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- SCH 23390—The first selective dopamine D-1 antagonistEuropean Journal of Pharmacology, 1983
- Multiple receptors for dopamineNature, 1979